WEST WARWICK – Profits for Astro-Med Inc. dropped 5.6 percent to $987,000, or 13 cents per diluted share, during the second quarter of 2012, compared with $1.05 million, or 14 cents per diluted share, during the second quarter of 2011.
The West Warwick-based high tech manufacturer saw its net sales drop 3.8 percent to $19.6 million during the three months ended July 28 from $20.3 million during the same quarter in 2011.
In addition, Astro-Med attributed a sales loss of $459,000, or 2.3 percent, to unfavorable foreign currency exchange rates.
For the six months ended July 28, Astro-Med reported net income of $1.82 million, or 24 cents per diluted share, a 23 percent increase from $1.48 million, or 20 cents per diluted share, reported during the first six months of 2011.
Astro-Med’s second-quarter net income included a tax benefit of $285,000, or 4 cents per diluted share, due to the favorable resolution of a previously uncertain tax position, according to the company.
“Astro-Med achieved another solid performance during the second quarter of fiscal year 2013,” Astro-Med President and CEO Everett V. Pizzuti said in prepared remarks.
“Astro-Med’s financial position remains very strong as detailed on its balance sheet. Cash and marketable securities declined slightly to $22.5 million, our working capital assets of accounts receivable and inventories declined by less than 2 percent from the year-end levels and reflect turnover rates of 50 days sales outstanding and 112 days of inventory on hand,” added Pizzuti.
The company also declared a regular quarterly cash dividend of 7 cents per share, payable on Oct. 4 to shareholders of record as of Sept. 14.
PBN's annual Book of Lists has been an essential resource for the local business community for almost 30 years. The Book of Lists features a wealth of company rankings from a variety of fields and industries, including banking, health care, real estate, law, hospitality, education, not-for-profits, technology and many more.